España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Rocket Pharmaceuticals
RCKT
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$13.04
0
0.00%
Pre-Market: 5:26 PM EDT
Get Report
Comment
Rocket Pharmaceuticals (RCKT) Forecast
News
Earnings
Rocket Pharmaceuticals (RCKT) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Rocket Pharmaceuticals (NASDAQ:RCKT) Stock
Rocket Pharmaceuticals Stock (NASDAQ: RCKT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, November 19, 2024
Canaccord Genuity Maintains Buy on Rocket Pha...
Benzinga Newsdesk
Rocket Pharmaceuticals' Gene Therapy Progress Boosts Confidence in Future Developments: Analyst
Vandana Singh
Leerink Partners Maintains Outperform on Rock...
Benzinga Newsdesk
Cantor Fitzgerald Reiterates Overweight on Ro...
Benzinga Newsdesk
Needham Reiterates Buy on Rocket Pharmaceutic...
Benzinga Newsdesk
Monday, November 18, 2024
Rocket Pharmaceuticals Announces New England ...
Benzinga Newsdesk
Tuesday, November 12, 2024
Rocket Pharmaceuticals To Present Updated Dat...
Benzinga Newsdesk
Monday, November 11, 2024
Chardan Capital Maintains Buy on Rocket Pharm...
Benzinga Newsdesk
Friday, November 08, 2024
Needham Reiterates Buy on Rocket Pharmaceutic...
Benzinga Newsdesk
Thursday, November 07, 2024
Rocket Pharmaceuticals Q3 2024 GAAP EPS $(0.7...
Benzinga Newsdesk
Wednesday, October 16, 2024
Rocket Pharmaceuticals shares are trading hig...
Benzinga Newsdesk
Scotiabank Initiates Coverage On Rocket Pharm...
Benzinga Newsdesk
Monday, September 30, 2024
Canaccord Genuity Maintains Buy on Rocket Pha...
Benzinga Newsdesk
Tuesday, September 17, 2024
Rocket Pharmaceuticals shares are trading hig...
Benzinga Newsdesk
Needham Reiterates Buy on Rocket Pharmaceutic...
Benzinga Newsdesk
Rocket Pharmaceuticals Announced That All Pat...
Benzinga Newsdesk
Monday, September 09, 2024
Rocket Stock Down More Than 30% in Past Six Months: Here's Why
Zacks
Monday, August 26, 2024
Galapagos, XPeng, CorMedix And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Friday, August 16, 2024
Rocket Pharmaceuticals Inc Files For Mixed Sh...
Benzinga Newsdesk
Tuesday, August 06, 2024
JP Morgan Maintains Overweight on Rocket Phar...
Benzinga Newsdesk
Cantor Fitzgerald Reiterates Overweight on Ro...
Benzinga Newsdesk
Chardan Capital Maintains Buy on Rocket Pharm...
Benzinga Newsdesk
Needham Reiterates Buy on Rocket Pharmaceutic...
Benzinga Newsdesk
Monday, August 05, 2024
Rocket Pharmaceuticals Q2 EPS $(0.74) Misses ...
Benzinga Newsdesk
Wednesday, July 03, 2024
Canaccord Genuity Maintains Buy on Rocket Pha...
Benzinga Newsdesk
Friday, June 28, 2024
Chardan Capital Maintains Buy on Rocket Pharm...
Benzinga Newsdesk
Needham Maintains Buy on Rocket Pharmaceutica...
Benzinga Newsdesk
FDA Rejects Rocket Pharmaceuticals' Gene Therapy For Rare Immune Disorder, Asks For More Data, Stock Slides
Vandana Singh
Nike, Accolade And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Avi Kapoor
Rocket Pharmaceuticals shares are trading low...
Benzinga Newsdesk
Trading Halt: Halt status updated at 7:55:00 ...
Benzinga Newsdesk
The FDA Issued Complete Response Letter To Ro...
Benzinga Newsdesk
Trading Halt: Halted at 6:56:37 a.m. ET - Tra...
Benzinga Newsdesk
Wednesday, May 29, 2024
European Commission Has Granted Orphan Medici...
Benzinga Newsdesk
Friday, May 10, 2024
Rocket Pharmaceuticals Presents Longer-Term D...
Benzinga Newsdesk
Tuesday, May 07, 2024
Needham Reiterates Buy on Rocket Pharmaceutic...
Benzinga Newsdesk
Monday, May 06, 2024
Rocket Pharmaceuticals Q1 EPS $(0.66) Beats $...
Benzinga Newsdesk
Tuesday, April 30, 2024
Rocket Pharmaceuticals Upgraded to Buy: Here's Why
Zacks
Wednesday, April 10, 2024
Needham Reiterates Buy on Rocket Pharmaceutic...
Benzinga Newsdesk
Tuesday, April 02, 2024
Goldman Sachs Initiates Coverage On Rocket Ph...
Benzinga Newsdesk
The European Medicines Agency Accepted The Ma...
Benzinga Newsdesk
Tuesday, March 26, 2024
Rocket Pharmaceuticals Announces Appointment Of Aaron Ondrey As Chief Financial Officer And Additional Updates To Corporate Leadership Team
Happy Mohamed
Friday, March 01, 2024
UBS Maintains Buy on Rocket Pharmaceuticals, ...
Benzinga Newsdesk
Tuesday, February 27, 2024
JP Morgan Maintains Overweight on Rocket Phar...
Benzinga Newsdesk
Cantor Fitzgerald Maintains Overweight on Roc...
Benzinga Newsdesk
Monday, February 26, 2024
Rocket Pharmaceuticals Q4 EPS $(0.64) Beats $(0.79) Estimate
Happy Mohamed
Tuesday, February 13, 2024
Needham Reiterates Buy on Rocket Pharmaceutic...
Benzinga Newsdesk
Rocket Pharmaceuticals Announced The FDA Has ...
Benzinga Newsdesk
Wednesday, January 31, 2024
Cantor Fitzgerald Reiterates Overweight on Ro...
Benzinga Newsdesk
Tuesday, December 05, 2023
Merit Medical Systems And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Lisa Levin
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch